Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published April 2023 | Published
Journal Article

Lineage Tracing and Single-Nucleus Multiomics Reveal Novel Features of Adaptive and Maladaptive Repair after Acute Kidney Injury

  • 1. ROR icon University of Southern California
  • 2. ROR icon University of California, San Francisco
  • 3. ROR icon European Molecular Biology Laboratory
  • 4. ROR icon Washington University in St. Louis
  • 5. ROR icon Kyoto Prefectural University of Medicine

Abstract

Significance Statement 

Understanding the mechanisms underlying adaptive and maladaptive renal repair after AKI and their long-term consequences is critical to kidney health. The authors used lineage tracing of cycling cells and single-nucleus multiomics (profiling transcriptome and chromatin accessibility) after AKI. They demonstrated that AKI triggers a cell-cycle response in most epithelial and nonepithelial kidney cell types. They also showed that maladaptive proinflammatory proximal tubule cells (PTCs) persist until 6 months post-AKI, although they decreased in abundance over time, in part, through cell death. Single-nucleus multiomics of lineage-traced cells revealed regulatory features of adaptive and maladaptive repair. These included activation of cell state–specific transcription factors and cis-regulatory elements, and effects in PTCs even after adaptive repair, weeks after the injury event.

Background 

AKI triggers a proliferative response as part of an intrinsic cellular repair program, which can lead to adaptive renal repair, restoring kidney structure and function, or maladaptive repair with the persistence of injured proximal tubule cells (PTCs) and an altered kidney structure. However, the cellular and molecular understanding of these repair programs is limited.

Methods 

To examine chromatin and transcriptional responses in the same cell upon ischemia-reperfusion injury (IRI), we combined genetic fate mapping of cycling (Ki67+) cells labeled early after IRI with single-nucleus multiomics—profiling transcriptome and chromatin accessibility in the same nucleus—and generated a dataset of 83,315 nuclei.

Results 

AKI triggered a broad cell cycle response preceded by cell type–specific and global transcriptional changes in the nephron, the collecting and vascular systems, and stromal and immune cell types. We observed a heterogeneous population of maladaptive PTCs throughout proximal tubule segments 6 months post-AKI, with a marked loss of maladaptive cells from 4 weeks to 6 months. Gene expression and chromatin accessibility profiling in the same nuclei highlighted differences between adaptive and maladaptive PTCs in the activity of cis-regulatory elements and transcription factors, accompanied by corresponding changes in target gene expression. Adaptive repair was associated with reduced expression of genes encoding transmembrane transport proteins essential to kidney function.

Conclusions 

Analysis of genome organization and gene activity with single-cell resolution using lineage tracing and single-nucleus multiomics offers new insight into the regulation of renal injury repair. Weeks to months after mild-to-moderate IRI, maladaptive PTCs persist with an aberrant epigenetic landscape, and PTCs exhibit an altered transcriptional profile even following adaptive repair.

Copyright and License

Copyright © 2023 by the American Society of Nephrology

Acknowledgement

We thank Dr. Seth Ruffins and the Optical Imaging Facility of USC Stem Cell for technical support.

Funding

L. M.S. Gerhardt was supported by the German Research Foundation with a postdoctoral scholarship (GE 3179/1-1).Work in A.P.M.’s laboratory was supported by a ReBuilding The Kidney Partnership grant from the National Institute of Diabetes and Digestive and Kidney Diseases (U01DK107350) and by a ReBuilding The Kidney Program grant (UC2DK126024).

Data Availability

Original data reported in this paper of type Experimental Data have been deposited to Gene Expression Omnibus (GEO), GSE209610.

This article contains the following supplemental material online at http://
links.lww.com/JSN/D619.

Contributions

L.M.S.Gerhardt, J. van Gestel, B.D.Humphreys, K. Koppitch, and A.P.McMahon conceptualized the study; L.M.S. Gerhardt was responsible for data curation and project administration and wrote the original draft; L.M.S.Gerhardt and H. Wu were responsible for visualization; L.M.S. Gerhardt, J. van Gestel, and K. Koppitch were responsible for formal analysis; H. Wu was responsible for software; L.M.S. Gerhardt, K. Koppitch, J. Guo, and S. Cho were responsible for validation; A. McMahon was responsible for funding acquisition and wrote the original draft; B. Humphreys, A. McMahon, were responsible for resources; B. Humphreys and A. P. McMahon provided supervision; L.M.S. Gerhardt and K. Koppitch were responsible for methodology.

Conflict of Interest

B.D.H. is a consultant Chinook Therapeutics, Janssen Research & Development, LLC, and Pfizer; holds equity in Chinook Therapeutics; and has had grant support from Chinook Therapeutics, Janssen and Pfizer (within last 3 years). B.Humphreys also reports Patents or Royalties: Evotec, AG; Advisory or Leadership Role: American Journal of Physiology Renal Physiology Editorial Board, ASCI President-elect, Board of Scientific Advisors, Chinook Therapeutics SAB, JCI Insight Editorial Board, Kidney International Editorial Board, Regenerative Medicine Crossing Borders SAB, RegMed XB, and Seminars in Nephrology Editorial Board.

A.P.M. receives consulting fees or stock options for his scientific advisory role for eGENESIS, IVIVAMedical, Novartis, and TRESTLE BioTherapeutics. A. McMahon also reports research funding: Amgen; Patents or Royalties: Hedgehog technology licenses through Harvard to Curis, received license/royalty payments from Curis; Advisory or Leadership Role: California Institute of Technology—Jacobs Institute, Max Planck Institute Molecular Genetics Berlin; and Other Interests or Relationships: Committee of University Kidney Research Organization (UKRO). J. van Gestel reports Employer: EMBL. All remaining authors have nothing to disclose.

Additional details

Created:
November 19, 2024
Modified:
November 19, 2024